ABL Bio (XKRX:298380) Accumulated Depreciation : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

ABL Bio's quarterly accumulated depreciation increased from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩-8,169 Mil) but then stayed the same from Dec. 2023 (₩-8,169 Mil) to Mar. 2024 (₩0 Mil).

ABL Bio's annual accumulated depreciation declined from Dec. 2021 (₩-6,251 Mil) to Dec. 2022 (₩-6,230 Mil) but then increased from Dec. 2022 (₩-6,230 Mil) to Dec. 2023 (₩-8,169 Mil).

ABL Bio Accumulated Depreciation Historical Data

The historical data trend for ABL Bio's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Accumulated Depreciation Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-2,512.76

-4,425.72

-6,250.98

-6,230.08

-8,168.93

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-8,168.93	-

ABL Bio Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

ABL Bio Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of ABL Bio's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines